• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项揭示中国红霉素耐药携带等位基因出现情况的横断面研究。

A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant Carrying Alleles in China.

作者信息

Wu Xiaoying, Du Qianqian, Li Dongfang, Yuan Lin, Meng Qinghong, Fu Zhou, Xu Hongmei, Yao Kaihu, Zhao Ruiqiu

机构信息

Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China.

Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

出版信息

Front Microbiol. 2022 Jul 18;13:901617. doi: 10.3389/fmicb.2022.901617. eCollection 2022.

DOI:10.3389/fmicb.2022.901617
PMID:35923401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9342848/
Abstract

BACKGROUND

Previous limited studies have identified that isolates circulating in China possess distinct molecular features and high rates of erythromycin-resistance (ER). Their evolution and potential impact on the prevention and control of global pertussis are worthy of attention.

METHODS

The present cross-sectional study involved 311 non-duplicate and unrelated strains isolated from Chinese children from 2017 to 2019. Their antimicrobial susceptibilities were assessed using both -test strips and Kirby-Bauer (KB) disk diffusion methods. Seven virulence-related genes (, , , , , , and ) and the A2047G mutation in the 23S rRNA gene were detected by PCR. Based on the susceptibilities and genotypes, 50 isolates were selected for multi-locus variable-number tandem-repeat analysis (MLVA) typing and whole-genome sequencing.

RESULTS

A total of 311 strains were isolated from children with a median age of 4 months (interquartile range: 2-9 months). Strains carrying the allele were more frequent (84.9%, 264/311), were always ER (except for one strain), and were mainly related to alleles (99.6%, 263/264). The remaining 47 (15.1%) strains carried the allele, mainly harboring the alleles (93.6%, 44/47), and were sensitive to erythromycin (except for two strains). The two ER- isolates were first identified in China, belonged to MT27 and MT28 according to MLVA, and were classified into sub-lineage IVd by phylogenetic analysis of their genome sequences. This sub-lineage also includes many strains carrying the allele spreading in developed countries. For each tested antimicrobial, the susceptibilities judged by KB disks were consistent with those determined by -test strips.

CONCLUSION

The present results reveal that strains with the -ER profile still dominate in China, and a few strains carrying the allele have acquired the A2047G mutation in the 23S rRNA gene and the ER phenotype. The surveillance of the drug susceptibility of is necessary for all countries, and the KB disk method can be adopted as a screening test.

摘要

背景

先前有限的研究已确定,在中国传播的分离株具有独特的分子特征和较高的红霉素耐药率(ER)。它们的进化及其对全球百日咳预防和控制的潜在影响值得关注。

方法

本横断面研究纳入了2017年至2019年从中国儿童中分离出的311株非重复且不相关的菌株。使用Etest试纸条和 Kirby-Bauer(KB)纸片扩散法评估它们的抗菌药物敏感性。通过聚合酶链反应(PCR)检测7个与毒力相关的基因(,,,,,,和)以及23S rRNA基因中的A2047G突变。根据药敏结果和基因型,选择50株分离株进行多位点可变数目串联重复序列分析(MLVA)分型和全基因组测序。

结果

共从年龄中位数为4个月(四分位间距:2 - 9个月)的儿童中分离出311株百日咳杆菌菌株。携带等位基因的菌株更为常见(84.9%,264/311),始终对红霉素耐药(除一株外),且主要与等位基因相关(99.6%,263/264)。其余47株(15.1%)携带等位基因,主要含有等位基因(93.6%,44/47),并且对红霉素敏感(除两株外)。这两株红霉素耐药分离株首次在中国被鉴定出来,根据MLVA属于MT27和MT28,通过对其基因组序列进行系统发育分析被归类为IVd亚系。该亚系还包括许多在发达国家传播的携带等位基因的菌株。对于每种测试的抗菌药物,KB纸片法判断的药敏结果与Etest试纸条法确定的结果一致。

结论

目前的结果表明,具有-ER表型的百日咳杆菌菌株在中国仍然占主导地位,少数携带等位基因的菌株在23S rRNA基因中获得了A2047G突变并呈现红霉素耐药表型。各国均有必要对百日咳杆菌进行药敏监测,KB纸片法可作为筛查试验采用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/b20780d90601/fmicb-13-901617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/d601dc87e4fe/fmicb-13-901617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/a4d452b342d5/fmicb-13-901617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/0ffe2fb4f8c7/fmicb-13-901617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/b20780d90601/fmicb-13-901617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/d601dc87e4fe/fmicb-13-901617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/a4d452b342d5/fmicb-13-901617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/0ffe2fb4f8c7/fmicb-13-901617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/9342848/b20780d90601/fmicb-13-901617-g004.jpg

相似文献

1
A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant Carrying Alleles in China.一项揭示中国红霉素耐药携带等位基因出现情况的横断面研究。
Front Microbiol. 2022 Jul 18;13:901617. doi: 10.3389/fmicb.2022.901617. eCollection 2022.
2
Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.2021年至2022年中国MT28 ptxP3等位基因大环内酯类耐药百日咳博德特氏菌的出现与传播
Int J Infect Dis. 2023 Mar;128:205-211. doi: 10.1016/j.ijid.2023.01.005. Epub 2023 Jan 9.
3
Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.中国深圳临床分离株百日咳博德特氏菌的分子流行病学和疫苗抗原基因分析。
Ann Clin Microbiol Antimicrob. 2021 Aug 18;20(1):53. doi: 10.1186/s12941-021-00458-3.
4
Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.1959年至2013年期间波兰百日咳博德特氏菌分离株毒力相关基因的序列变异
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):147-152. doi: 10.1007/s10096-014-2216-6. Epub 2014 Aug 5.
5
Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.2016-2022 年中国上海百日咳博德特氏菌的分子进化和大环内酯类耐药性增加。
Emerg Infect Dis. 2023 Jan;30(1):29-38. doi: 10.3201/eid3001.221588.
6
Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).中国百日咳博德特氏菌对红霉素的敏感性及毒力相关基因型变化(1970 - 2014年)
PLoS One. 2015 Sep 25;10(9):e0138941. doi: 10.1371/journal.pone.0138941. eCollection 2015.
7
Macrolide susceptibility and molecular characteristics of .肺炎支原体对大环内酯类药物的敏感性及分子特征。
J Int Med Res. 2022 Feb;50(2):3000605221078782. doi: 10.1177/03000605221078782.
8
High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.2014-2016 年中国大陆地区大环内酯类耐药百日咳博德特氏菌流行率高及 ptxP1 基因型占主导地位。
Emerg Infect Dis. 2019 Dec;25(12):2205-2214. doi: 10.3201/eid2512.181836.
9
[Antimicrobial susceptibility and antigen genotypes of Bordetella pertussis strains isolated from neonates].从新生儿中分离出的百日咳博德特氏菌菌株的抗菌药敏性及抗原基因型
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Mar;21(3):208-213. doi: 10.7499/j.issn.1008-8830.2019.03.004.
10
Emerging of ptxP3 lineage in Bordetella pertussis strains circulating in a population in northeastern Mexico.在墨西哥东北部流行的百日咳博德特氏菌菌株中出现了 ptxP3 谱系。
Epidemiol Infect. 2018 Dec;146(16):2096-2101. doi: 10.1017/S0950268818002303. Epub 2018 Aug 23.

引用本文的文献

1
Macrolide-Resistant in Hong Kong: Evidence for Post-COVID-19 Emergence of -Lineage MT28 Clone from a Hospital-Based Surveillance Study.香港的大环内酯类耐药性:一项基于医院监测研究的新冠疫情后出现的MT28谱系克隆的证据。
Microorganisms. 2025 Aug 20;13(8):1947. doi: 10.3390/microorganisms13081947.
2
[Potential impact of adjusting immunization procedure for diphtheria-tetanus-pertussis vaccine on pertussis in clinical practice].调整白喉-破伤风-百日咳疫苗免疫程序对临床实践中百日咳的潜在影响
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):786-791. doi: 10.7499/j.issn.1008-8830.2501077.
3
Waning immunity, prevailing non-vaccine type and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.

本文引用的文献

1
Evolution of over a 23-year period in France, 1996 to 2018.23 年间法国的演变,1996 年至 2018 年。
Euro Surveill. 2021 Sep;26(37). doi: 10.2807/1560-7917.ES.2021.26.37.2001213.
2
Emerging macrolide resistance in in mainland China: Findings and warning from the global pertussis initiative.中国大陆新出现的大环内酯类耐药性:全球百日咳倡议的发现与警示
Lancet Reg Health West Pac. 2021 Feb 5;8:100098. doi: 10.1016/j.lanwpc.2021.100098. eCollection 2021 Mar.
3
Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences.
中国2024年百日咳疫情中的免疫衰退、流行的非疫苗型及大环内酯类耐药菌株:一项多中心横断面描述性研究
Lancet Reg Health West Pac. 2025 Jul 4;60:101628. doi: 10.1016/j.lanwpc.2025.101628. eCollection 2025 Jul.
4
The potential of wastewater monitoring as a novel surveillance tool for early warning of outbreaks.废水监测作为疫情早期预警新型监测工具的潜力。
Emerg Microbes Infect. 2025 Dec;14(1):2528537. doi: 10.1080/22221751.2025.2528537. Epub 2025 Jul 10.
5
Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance.百日咳的死灰复燃:流行病学趋势、促成因素、挑战以及疫苗接种和监测建议。
Hum Vaccin Immunother. 2025 Dec;21(1):2513729. doi: 10.1080/21645515.2025.2513729. Epub 2025 Jun 9.
6
Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern China.中国北方高毒力百日咳博德特氏菌对大环内酯类药物耐药性急剧上升。
Emerg Microbes Infect. 2025 Dec;14(1):2475841. doi: 10.1080/22221751.2025.2475841. Epub 2025 Mar 18.
7
Genomic epidemiology and evolution of under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023.2020 - 2023年中国北京无细胞疫苗接种压力下的基因组流行病学及演变
Emerg Microbes Infect. 2025 Dec;14(1):2447611. doi: 10.1080/22221751.2024.2447611. Epub 2025 Jan 8.
8
Expert consensus for pertussis in children: new concepts in diagnosis and treatment.儿童百日咳专家共识:诊断与治疗的新概念
World J Pediatr. 2024 Dec;20(12):1209-1222. doi: 10.1007/s12519-024-00848-5. Epub 2024 Nov 14.
9
Rising pertussis cases and deaths in China: current trends and clinical solutions.中国百日咳病例和死亡人数上升:当前趋势和临床解决方案。
Emerg Microbes Infect. 2024 Dec;13(1):2389086. doi: 10.1080/22221751.2024.2389086. Epub 2024 Aug 21.
10
Molecular epidemiology and genomic features of in Shanghai, China, 2017-2022.2017 - 2022年中国上海[具体研究对象]的分子流行病学及基因组特征
Front Microbiol. 2024 Jul 9;15:1428766. doi: 10.3389/fmicb.2024.1428766. eCollection 2024.
百日咳博德特氏菌感染的药物治疗。二、临床科学的综合。
Int J Antimicrob Agents. 2021 Mar;57(3):106257. doi: 10.1016/j.ijantimicag.2020.106257. Epub 2020 Dec 11.
4
Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences.百日咳博德特氏菌感染的药物治疗。一、实验室科学综述。
Int J Antimicrob Agents. 2021 Mar;57(3):106258. doi: 10.1016/j.ijantimicag.2020.106258. Epub 2020 Dec 11.
5
The epidemic of erythromycin-resistant with limited genome variation associated with pertussis resurgence in China.中国百日咳卷土重来与有限基因组变异的红霉素耐药相关的流行。
Expert Rev Vaccines. 2020 Nov;19(11):1093-1099. doi: 10.1080/14760584.2020.1831916. Epub 2020 Oct 21.
6
Effect of Macrolides and β-lactams on Clearance of Bordetella pertussis in the Nasopharynx in Children With Whooping Cough.大环内酯类和β-内酰胺类药物对百日咳患儿鼻咽部博德特氏菌清除率的影响。
Pediatr Infect Dis J. 2021 Feb 1;40(2):87-90. doi: 10.1097/INF.0000000000002911.
7
Macrolide-Resistant Bordetella pertussis, Vietnam, 2016-2017.2016-2017 年越南耐大环内酯类百日咳博德特氏菌。
Emerg Infect Dis. 2020 Oct;26(10):2511-2513. doi: 10.3201/eid2610.201035.
8
The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.日本首例大环内酯类耐药百日咳博德特氏菌的分离报告。
Jpn J Infect Dis. 2020 Sep 24;73(5):361-362. doi: 10.7883/yoken.JJID.2019.421. Epub 2020 Apr 30.
9
Population dynamics and antigenic drift of following whole cell vaccine replacement, Barcelona, Spain, 1986-2015.人群动态和抗原漂移与全细胞疫苗替代的关系:西班牙巴塞罗那,1986-2015 年。
Emerg Microbes Infect. 2019;8(1):1711-1720. doi: 10.1080/22221751.2019.1694395.
10
High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.2014-2016 年中国大陆地区大环内酯类耐药百日咳博德特氏菌流行率高及 ptxP1 基因型占主导地位。
Emerg Infect Dis. 2019 Dec;25(12):2205-2214. doi: 10.3201/eid2512.181836.